Sign In
Book a Demo
Dr. Ginna G. Laport, MD
About ProfilePoints™
0 Patient Reviews

Dr. Ginna G. Laport, MD

Hematology / Oncology Specialist - Hematologist (Blood)

Highlights

  • Board Certified
  • Accepts Insurance Plans

Biography

Dr. Ginna G. Laport, MD is a Hematology / Oncology Specialist - Hematologist (Blood) practicing in Stanford, CA

She has not yet shared a personalized biography with Doctor.com.

View Phone #Call Now

Are you Dr. Ginna G. Laport, MD?

Claim your 100% free Doctor.com profile to:

  • Respond to patient reviews
  • Customize your profile
  • Improve your visibility to our millions of monthly users
Claim your profile

Provider Training

UniversityDegreeFocusGraduated
U of Tx Medical School At Houston, Houston TxOther Degree1990
University of Texas Medical School, HoustonOther Degree1990

InstitutionFocusYear
Internship - University of Chicago Hospitals1991
Residency - University Of Chicago Hosps, Internal MedicineNot Specified
Residency - University of Chicago Hospitals1993
Fellowship - Stanford University School of Medicine,Stanford, Ca, United States1994

CertificationCert. BodyYear
Internal medicineInternal MedicineNot Specified

Experience & Accolades

PositionOrganizationTime
Professor of Medicine (Blood and Marrow Transplantation)the Stanford University Medical Center
Present

Publication Publisher Title Published
Other PublicationJourl of clinical oncologyAutologous or reduced2014
Other PublicationBRITISH JOURL OF HAEMATOLOGYAutologous haematopoietic cell transplantation for non2013
Other PublicationJOURL OF CLINICAL ONCOLOGYHematopoietic Cell Transplantation for Systemic Mature T-Cell Non-Hodgkin Lymphoma2013
Other PublicationJOURL OF CLINICAL ONCOLOGYGraft-Versus-Host Disease2013
Other PublicationKate, A. S., Efron, B., Chhabra, S., Kohrt, H., Shizuru, J. A., LaportOutcomes After Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation with Total Lymphoid2013
Other PublicationBIOLOGY OF BLOOD AND MARROW TRANSPLANTATIONAlterte Donor Hematopoietic Cell Transplantation2012
Other PublicationBIOLOGY OF BLOOD AND MARROW TRANSPLANTATIONFollicular Lymphoma: Prognostic Factors, Conventiol Therapies2012
Other PublicationHari, P., Pasquini, M. C., Logan, B. R., Stadtmauer, E. A., Krishn, A.Immunoglobulin Free Light Chain (FLC) and Heavy Chain2011
Other PublicationJAMA-JOURL OF THE AMERICAN MEDICAL ASSOCIATIONLong-term Outcomes Among Older Patients Following Nonmyeloablative Conditioning2011
Other PublicationHAEMATOLOGICA-THE HEMATOLOGY JOURLNon-myeloablative conditioning with allogeneic hematopoietic cell transplantation for the treatment2011
Other PublicationBONE MARROW TRANSPLANTATIONLong-term outcomes in patients with high2011
Other Publicationik, S. G., Negrin, R., Laport, G., Miklos, D., Shizuru, J., Arai, S., Long-term outcomes of high-dose therapy using busulfan, etoposide
Other PublicationNEW ENGLAND JOURL OF MEDICINEProtective conditioning for acute graft-versus-host disease2005
Other PublicationLEUKEMIA RESEARCHMultiple unrelated clol abnormalities2004
Other PublicationJOURL OF HEMATOTHERAPY & STEM CELL RESEARCHSoluble interleukin-2 receptor concentration as a biochemical indicator for acute graft2000
Other PublicationSEMIRS IN ONCOLOGYThe role of high-dose chemotherapy in patients with Hodgkin's disease and non-Hodgkin's lymphoma1998
Other PublicationSEMIRS IN ONCOLOGYTreatment of adult acute lymphoblastic leukemia1997
Other PublicationBiology of blood and marrow transplantationTotal lymphoid irradiation-antithymocyte globulin conditioning2014
Other PublicationJournal of clinical oncologyAutologous or reduced2014
Other PublicationBLOODProspective cohort study comparing intravenous busulfan to total body irradiation2013
Other PublicationBIOLOGY OF BLOOD AND MARROW TRANSPLANTATIONSimplified Validated Prognostic Model for Progression2013
Other PublicationBRITISH JOURNAL OF HAEMATOLOGYAutologous haematopoietic cell transplantation for non2013
Other PublicationJOURNAL OF CLINICAL ONCOLOGYHematopoietic Cell Transplantation for Systemic Mature T-Cell Non-Hodgkin Lymphoma2013
Other PublicationBIOLOGY OF BLOOD AND MARROW TRANSPLANTATIONImpact of Pretransplantation Conditioning Regimens on Outcomes of Allogeneic Transplantation2013
Other PublicationJOURNAL OF CLINICAL ONCOLOGYGraft-Versus-Host Disease2013
Other PublicationKanate, A. S., Efron, B., Chhabra, S., Kohrt, H., Shizuru, J. A., LapoOutcomes After Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation with Total Lymphoid2013
Other PublicationBenjamin, J., Chhabra, S., Kohrt, H., Laport, G. G., Arai, S., JohnstoTLI-ATG Conditioning and Allogeneic Transplantation for Patients with MDS and MPN2013
Other PublicationBenjamin, J., Chhabra, S., Kohrt, H. E., Laport, G. G., Arai, S., JohnNon-Myeloablative Conditioning with Total Lymphoid Irradiation and ATG and Allogeneic
Other PublicationBLOODConditioning regimens for allotransplants for diffuse large B-cell lymphoma2012
Other PublicationBONE MARROW TRANSPLANTATIONPalifermin for the reduction of acute GVHD: a randomized, double-blind, placebo-controlled trial2012
Other PublicationBIOLOGY OF BLOOD AND MARROW TRANSPLANTATIONAlternate Donor Hematopoietic Cell Transplantation2012
Other PublicationBLOODProphylactic rituximab after allogeneic transplantation decreases B2012
Other PublicationBIOLOGY OF BLOOD AND MARROW TRANSPLANTATIONTandem Transplantation for Follicular Lymphoma: The Best of Both Worlds?2012
Other PublicationBONE MARROW TRANSPLANTATIONTandem chemo-mobilization followed by high2012
Other PublicationBONE MARROW TRANSPLANTATIONSirolimus and mycophenolate mofetil as GVHD prophylaxis in myeloablative2012
Other PublicationHematology / the Education Program of the American Society of HematoloChanging role of stem cell transplantation in follicular lymphoma.2012
Other PublicationBIOLOGY OF BLOOD AND MARROW TRANSPLANTATIONFollicular Lymphoma: Prognostic Factors, Conventional Therapies2012
Other PublicationBIOLOGY OF BLOOD AND MARROW TRANSPLANTATIONLong-Term Outcome of Patients with Metastatic Breast Cancer Treated with High-Dose Chemotherapy2012
Other PublicationLANCET ONCOLOGYAutologous haemopoietic stem2011
Other PublicationHari, P., Pasquini, M. C., Logan, B. R., Stadtmauer, E. A., Krishnan, Immunoglobulin Free Light Chain (FLC) and Heavy Chain2011
Other PublicationJAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATIONLong-term Outcomes Among Older Patients Following Nonmyeloablative Conditioning2011
Other PublicationBIOLOGY OF BLOOD AND MARROW TRANSPLANTATIONAdoptive Immunotherapy with Cytokine2011
Other PublicationHAEMATOLOGICA-THE HEMATOLOGY JOURNALNon-myeloablative conditioning with allogeneic hematopoietic cell transplantation for the treatment2011
Other PublicationBIOLOGY OF BLOOD AND MARROW TRANSPLANTATIONAutologous versus Reduced2011
Other PublicationMueller, A. M., Kohrt, H. E., Laport, G. G., Negrin, R. S., Cha, S., WLONG-TERM FOLLOW-UP OF METASTATIC BREAST CANCER PATIENTS RECEIVING HIGHLY PURIFIED AUTOLOGOUS2011
Other PublicationBONE MARROW TRANSPLANTATIONLong-term outcomes in patients with high2011
Other PublicationCURRENT OPINION IN ONCOLOGYPeripheral T-cell lymphoma: autologous hematopoietic cell transplantation as first-line therapy2010
Other PublicationBIOLOGY OF BLOOD AND MARROW TRANSPLANTATIONPhase I/II Trial of GN-BVC2010
Other PublicationLi, L., Kohrt, H., Heish, S., Alizadeh, A., Laport, G., Shizuru, J., NNoninvasive Prediction of Graft-Versus2010
Other PublicationBIOLOGY OF BLOOD AND MARROW TRANSPLANTATIONThe Role of Cytotoxic Therapy with Hematopoietic Stem Cell Transplantation2010
Other PublicationBONE MARROW TRANSPLANTATIONLong-term follow-up of patients with diffuse large B-cell non-Hodgkin's lymphoma receiving purged2010
Other PublicationBLOODTLI and ATG conditioning with low risk of graft-versus2009
Other PublicationNaik, S. G., Negrin, R., Laport, G., Miklos, D., Shizuru, J., Arai, S.Long-term outcomes of high-dose therapy using busulfan, etoposide
Other PublicationKohrt, H., Turnbull, B., Laport, G., Miklos, D., Shizuru, J., JohnstonOutcomes Following Allogeneic Hematopoietic Cell Transplantation2008
Other PublicationArai, S., Sahaf, B., Jones, C., Zhender, J., Lowsky, R., Strober, S., Prophylactic Rituximab after Reduced Intensity Conditioning Transplantation Results2008
Other PublicationArai, S., Letsinger, R., Johnston, L., Laport, G., Lowsky, R., Miklos,Phase I/II Trial of a Novel Gemcitabine2008
Other PublicationBLOODLong-term remission of Philadelphia chromosome2008
Other PublicationBIOLOGY OF BLOOD AND MARROW TRANSPLANTATIONLong-term results of autologous hematopoietic cell transplantation for peripheral T cell lymphoma2008
Other PublicationLaport, G., Bredeson, C., Tomblyn, M. R., Kahl, B. S., Goodman, S. A.,Autologous versus reduced
Other PublicationBIOLOGY OF BLOOD AND MARROW TRANSPLANTATIONReduced-intensity conditioning follow by allogeneic hematopoietic cell transplantation for adult2008
Other PublicationBIOLOGY OF BLOOD AND MARROW TRANSPLANTATIONControversies in lymphoma2008
Other PublicationLEUKEMIA & LYMPHOMAAllogeneic hematopoietic cell transplantation for Hodgkin lymphoma: a concise review2008
Other PublicationArai, S., Sheehan, K., Moore, S., Laport, G., Johnston, L., Lowsky, R.Autologous cytokine-induced killer cells as post-transplant cellular immunotherapy2007
Other PublicationBIOLOGY OF BLOOD AND MARROW TRANSPLANTATIONMantle cell lymphoma in first complete remission2007
Other PublicationArai, S., Sahaf, B., Jones, C., Zehnder, J., Lowsky, R., Strober, S., Rituximab infusion two months after total lymphoid irradiation-antithymocyte globulin2007
Other PublicationArai, S., Sahaf, B., Jones, C., Zehnder, J., Lowsky, R., Strober, S., Rituximab infusion two months after nonmyeloablative transplantation maintains B2006
Other PublicationLowsky, R., Stockert-Goldstein, K., Laport, G., Miklos, D., Arai, S., Clinical outcomes following allogeneic hematopoietic cell transplantation2006
Other PublicationLaport, G. G., Sheehan, K., Lowsky, R., Shizuru, J. A., Stockerl-GoldsCytokine induced killer2006
Other PublicationCao, T. M., Stockerl-Goldstein, K. E., Cao, P. D., Laport, G. G., SheeHigh dose therapy and autologous hematopoietic cell transplantation for primary refractory diffuse2006
Other PublicationBIOLOGY OF BLOOD AND MARROW TRANSPLANTATIONHigh-dose carmustine, etoposide2006
Other PublicationBIOLOGY OF BLOOD AND MARROW TRANSPLANTATIONThe role of hematopoietic cell transplantation for follicular non-Hodgkin's lymphoma2006
Other PublicationLowsky, R., Heydari, K., Sahaf, B., Shizuru, J., Laport, G., Johnston,Haploidentical non-myeloablative allogeneic hematopoietic cell transplantation2005
Other PublicationBONE MARROW TRANSPLANTATIONRhabdomyolysis after concomitant use of cyclosporine2005
Other PublicationNEW ENGLAND JOURNAL OF MEDICINEProtective conditioning for acute graft-versus-host disease2005
Other PublicationArai, S., Negrin, R., Blume, K., Johnston, L., Laport, G., Lowsky, R.,A phase I trial with extended cohort of gemcitabine2005
Other PublicationBLOODEngraftment and survival following reduced-intensity allogeneic peripheral blood hematopoietic cell2005
Other PublicationEXPERIMENTAL HEMATOLOGYCD34, CD49 and CD8 cell doses do not influence engraftment2005
Other PublicationCao, T. M., Shizuru, J. A., Wong, R. M., Sheehan, K., Laport, G. G., SEngraftment and survival following non-myeloablative allogeneic peripheral blood hematopoietic cell2004
Other PublicationLEUKEMIA RESEARCHMultiple unrelated clonal abnormalities2004
Other PublicationLowsky, R., Jones, S. D., Mitra, S., Shizuru, J. A., Laport, G. G., StNon-myeloablative conditioning with total lymphoid irradiation (TLI)2003
Other PublicationBLOODAdoptive transfer of costimulated T cells induces lymphocytosis in patients with relapsed2003
Other PublicationCurrent hematology reportsNonmyeloablative allogeneic stem cell transplantation for acute leukemia.2003
Other PublicationBONE MARROW TRANSPLANTATIONA phase II trial of docetaxel for peripheral blood stem cell mobilization for patients2001
Other PublicationBIOLOGY OF BLOOD AND MARROW TRANSPLANTATIONAllogeneic cell therapy for patients who relapse after autologous stem cell transplantation2001
Other PublicationJOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCHSoluble interleukin-2 receptor concentration as a biochemical indicator for acute graft2000
Other PublicationBONE MARROW TRANSPLANTATIONA dose escalation study of total body irradiation followed by high-dose etoposide2000
Other PublicationCYTOTHERAPYTransplantation with low-density autologous PBSC prepared with BDS60 for women with stage II2000
Other PublicationSEMINARS IN ONCOLOGYThe role of high-dose chemotherapy in patients with Hodgkin's disease and non-Hodgkin's lymphoma1998
Other PublicationBONE MARROW TRANSPLANTATIONHigh-dose chemotherapy consolidation with autologous stem cell rescue in metastatic breast cancer1998
Other PublicationSEMINARS IN ONCOLOGYTreatment of adult acute lymphoblastic leukemia1997

Practice & Hospital Affiliations

Dr. Ginna G. Laport, MD has not yet indicated the hospitals that she is affiliated with.

Photos

Provider Profile 0Provider Profile 1

Specialties

Languages Spoken
English
Medical Specialties
  • Hematology / Oncology Specialist - Sub-Specialty: Hematologist (Blood)

Internal Medicine

Years In Practice: 27 (started in 1997)

Accepts New Patients: Yes

Accepted Insurance

Full Insurance List

Payment Options

Payment Details
We use cookies and limited processing of your personal information for our website and services to function. By using our site, you agree to our use of cookies and our privacy policy.
I Accept